KOBLISH ANTONY 4
4 · TELA Bio, Inc. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
KOBLISH ANTONY
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2024-02-24$7.07/sh−5,726$40,483→ 370,394 total - Award
Stock Option (Right to Buy)
2024-02-23+113,200→ 113,200 totalExercise: $7.07Exp: 2034-02-23→ Common Stock (113,200 underlying) - Award
Common Stock
2024-02-23+77,500→ 381,134 total - Tax Payment
Common Stock
2024-02-23$7.07/sh−5,014$35,449→ 376,120 total
Footnotes (3)
- [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
- [F3]The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.